HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Heinz Kutzner Selected Research

Blue Nevus

4/2004The anti-MAGE antibody B57 as a diagnostic marker in melanocytic lesions.
2/2002Congenital giant melanocytic nevus with pigmented epithelioid cells: a variant of epithelioid blue nevus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Heinz Kutzner Research Topics

Disease

31Neoplasms (Cancer)
11/2015 - 05/2002
9Melanoma (Melanoma, Malignant)
05/2015 - 06/2002
7Infection
03/2015 - 02/2007
4Hyperplasia
05/2013 - 10/2005
4Carcinoma (Carcinomatosis)
05/2009 - 03/2002
4Nevus (Nevi)
10/2008 - 11/2003
4Lymphoma (Lymphomas)
06/2008 - 05/2002
3Inflammation
10/2015 - 01/2009
3Hemangioendothelioma
02/2013 - 06/2006
3Cicatrix (Scar)
08/2012 - 05/2004
3Pigmented Nevus (Melanocytic Nevus)
11/2010 - 04/2004
3Lymphoproliferative Disorders (Lymphoproliferative Disorder)
02/2009 - 05/2002
2Vasculitis (Vasculitides)
10/2015 - 09/2015
2Granuloma
10/2015 - 12/2006
2Sarcoma (Soft Tissue Sarcoma)
07/2015 - 02/2013
2Fibroma (Fibromatosis)
07/2015 - 02/2010
2Halo Nevus
05/2015 - 04/2004
2Pseudolymphoma
03/2015 - 10/2006
2Panniculitis
04/2013 - 12/2006
2Epithelioid Hemangioendothelioma
02/2013 - 02/2008
2Cysts
07/2012 - 12/2008
2Basal Cell Carcinoma (Rodent Ulcer)
07/2012 - 05/2009
2Sarcoidosis (Schaumann Disease)
10/2011 - 08/2007
2Skin Diseases
11/2010 - 07/2005
2Hamartoma
02/2010 - 02/2006
2Renal Insufficiency (Renal Failure)
10/2009 - 06/2003
2Nephrogenic Fibrosing Dermopathy
10/2009 - 06/2003
2T-Cell Lymphoma (Lymphoma, T Cell)
06/2008 - 05/2002
2Hemangiosarcoma (Angiosarcoma)
08/2007 - 03/2002
2Hemangioma (Angioma)
02/2006 - 05/2004
2Blue Nevus
04/2004 - 02/2002
2Kaposi Sarcoma (Kaposi's Sarcoma)
09/2002 - 03/2002
1Lymphangiectasis
10/2015
1Alopecia (Baldness)
10/2015
1Endarteritis
10/2015
1Pathologic Constriction (Stenosis)
10/2015
1Epstein-Barr Virus Infections
09/2015
1Ulcer
09/2015
1Benign Fibrous Histiocytoma (Dermatofibroma)
07/2015
1Neurofibroma
07/2015
1Myxoma (Myxomas)
07/2015
1Borrelia Infections
04/2015
1Herpes Simplex
01/2015
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2014
1Perivascular Epithelioid Cell Neoplasms
07/2013
1Wounds and Injuries (Trauma)
10/2012
1Pseudoxanthoma Elasticum (Gronblad Strandberg Syndrome)
08/2012
1Keratosis
07/2012
1Sweat Gland Neoplasms
07/2012

Drug/Important Bio-Agent (IBA)

5CollagenIBA
03/2011 - 07/2005
5Melanins (Melanin)IBA
02/2010 - 02/2002
4Dermatofibrosarcoma protuberansIBA
07/2015 - 02/2010
4Proteins (Proteins, Gene)IBA
03/2014 - 06/2008
3MART-1 AntigenIBA
11/2015 - 02/2006
3Phosphotransferases (Kinase)IBA
07/2014 - 03/2004
3Kaposiform HemangioendotheliomaIBA
02/2013 - 02/2008
3ParaffinIBA
08/2012 - 04/2004
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2011 - 10/2005
3AntibodiesIBA
11/2010 - 03/2003
3VimentinIBA
02/2008 - 08/2002
3Formaldehyde (Formol)FDA Link
11/2006 - 04/2004
3tebufenozide (Mimic)IBA
09/2002 - 03/2002
2AntigensIBA
10/2015 - 09/2009
2Phenobarbital (Luminal)FDA Link
10/2015 - 10/2007
2glucuronyl glucosamine glycan sulfate (Vessel)IBA
09/2015 - 10/2005
2S100 Proteins (S 100 Protein)IBA
03/2014 - 05/2003
2Eosine Yellowish-(YS) (Eosin)IBA
10/2010 - 01/2006
2Hematoxylin (Haematoxylon)IBA
10/2010 - 01/2006
2MucinsIBA
10/2009 - 09/2006
2DNA (Deoxyribonucleic Acid)IBA
05/2009 - 11/2005
2Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
10/2006 - 10/2005
2DesminIBA
02/2006 - 01/2006
2calponinIBA
02/2006 - 05/2003
2Mucin-1 (CA 15-3 Antigen)IBA
02/2006 - 10/2005
1adipophilinIBA
11/2015
1Erythema elevatum diutinumIBA
10/2015
1Prednisone (Sone)FDA LinkGeneric
10/2015
1Syntex adjuvant formulationIBA
07/2015
1Granzymes (Granzyme)IBA
05/2015
1Erythema migransIBA
04/2015
1Bacterial AntigensIBA
03/2015
1Phenytoin (Dilantin)FDA LinkGeneric
03/2015
1Monoclonal AntibodiesIBA
01/2015
1imatinib (Gleevec)FDA Link
05/2014
1Cadherins (E-Cadherin)IBA
03/2014
1N-desmethylstobadineIBA
03/2014
1PlasticsIBA
02/2014
1Cyclin-Dependent Kinase Inhibitor p16IBA
08/2013
1Differentiation AntigensIBA
07/2013
1TESIBA
05/2013
1Biological Markers (Surrogate Marker)IBA
05/2013
1tranilast (N 5')IBA
05/2013
1Subcutaneous panniculitis-like T-cell lymphomaIBA
04/2013
1CosmeticsIBA
10/2012
1Fluorescent Dyes (Fluorescent Probes)IBA
08/2012
1Serum Amyloid P-ComponentIBA
08/2012
1calretininIBA
07/2012
1Viral DNAIBA
12/2011
1Histones (Histone)IBA
10/2010

Therapy/Procedure

1Lymph Node Excision (Lymph Node Dissection)
04/2015